The use of cardiomyocyte-specific MT and Nrf2 transgenics that were shown to alleviate DM-induced cardiac fibrosis will allow us to determine whether lung fibrosis occurs independently from cardiac fibrosis, should these mice still develop lung fibrosis. Here, NFE2L2 is linked to diabetes mellitus.